Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review

BACKGROUND: It is unclear whether immunotherapy for combined pulmonary fibrosis and emphysema (CPFE) with advanced lung cancer (CPFE-LC) is safe. CASE DESCRIPTION: We reported on two cases of primary CPFE-LC, where the initial focus was on the lung cancer and not on the CPFE. The two patients underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Xianglan, Tang, Xi, Jiang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745352/
https://www.ncbi.nlm.nih.gov/pubmed/36523303
http://dx.doi.org/10.21037/tcr-22-1526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745352/
https://www.ncbi.nlm.nih.gov/pubmed/36523303
http://dx.doi.org/10.21037/tcr-22-1526

Ejemplares similares